Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

Documents similaires

• Invited commentary: Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
  par: Marc Pocard
  Publié: (2024)
• Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study
  par: Lana Ghanipour, et autres
  Publié: (2025)
• Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases
  par: Nadina Tinsley, et autres
  Publié: (2024)
• Population pharmacokinetics of intraperitoneal irinotecan and SN‐38 in patients with peritoneal metastases from colorectal origin
  par: Pascale C. S. Rietveld, et autres
  Publié: (2024)
• Reported outcomes following cytoreductive surgery for colorectal peritoneal metastases: A systematic review to inform evidence‐based practice and international consensus
  par: Pratik Raichurkar, et autres
  Publié: (2024)